Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Liver Neoplasms 1Fatigue 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Patient Education as Topic × Clear all
NCT06384950 2024-04-25

Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma

Taipei Veterans General Hospital, Taiwan

Phase NA Unknown
450 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02582918 2022-09-28

Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5

University of Texas Southwestern Medical Center

Phase NA Completed
2,871 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡